Translational oncology
Cure8 research brief
Why This Matters
Researchers and clinicians interested in cross-disease host–microbe interactions may find that an IBD–CRC shared microbial/host signature could have prognostic importance beyond the gut, here in bladder cancer.
The work suggests shared biology between inflammatory/colitic disease signatures and tumor microenvironment features relevant to immune response and subtype classification.
Who Should Pay Attention
Researchers studying the microbiome, tumor immunology, multi-omics integration, and pathology AI; clinicians and translational scientists focused on bladder cancer and cross-disease biomarker discovery.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This study (abstract) reports that an IBD–colorectal cancer shared host–microbe gene signature has prognostic value in bladder urothelial carcinoma (BLCA).
Using TCGA multi-omics data, machine learning (LASSO-Cox), single-cell and spatial transcriptomics, immunohistochemistry, and an attention-based multiple instance learning model on H&E whole-slide images, the authors linked high signature activity to worse BLCA prognosis, basal/squamous features, and an immunosuppressive tumor microenvironment.
The pathology AI model was trained and internally validated on TCGA and externally validated on an independent cohort (n=39) with an internal AUC reported.
Keep In Mind
This record is an abstract-level report of an integrated multi-omics and machine-learning analysis; it does not report interventional results or clinical utility testing in prospective trials. The relevance to patients with IBD is indirect—this study evaluates a shared signature in bladder cancer, not IBD clinical outcomes.
External validation of prognostic utility and clinical impact would require further studies.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationTranslational oncology
AuthorsChangxin Zhan, Ting Xu, Hongshen Lai +7 more
InstitutionDepartment of Urology, The People's Hospital of Longhua Shenzhen, 38 Jinglong Jianshe Road, Longhua District, Shenzhen, Guangdong, 518109, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedSep 9, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest There are no conflicts to declare.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Multi-omics analysis identifies macrophage immunometabolic signatures in ulcerative colitis
The work highlights macrophage metabolic programs and specific genes that may help classify UC molecular subtypes and suggest candidate biomarkers or therapeutic targets related to macrophage-driven inflammation.
Quantitative image feature integrated digital pathology model based on deep learning and machine learning for binary histological severity stratification of ulcerative colitis
Automated, quantitative analysis of pathology slides could reduce variability in histological scoring and help track histological healing — a growing therapeutic target in ulcerative colitis.
Machine learning-driven identification and experimental validation of key biomarkers in the bile acid metabolic pathway associated with ulcerative colitis.
The study suggests specific bile-acid–related genes that are altered in UC and linked to immune-cell changes, which could help researchers and clinicians exploring new biomarkers or mechanisms behind inflammation in UC.